New data presented at ACC 2026 clarifies sotatercept’s role alongside vasodilator-based regimens in PAH patients.
Background Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions ...
KOLs note that CagriSema could cannibalise semaglutide's market share in obesity due to its improved efficacy.
Sometimes, psychological studies on the same topic show different results. To know what the evidence looks like when the data from all studies on a topic are combined, psychologists often conduct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results